|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Das M: Cabozantinib improves clinical
outcomes in renal cancer. Lancet Oncol. 18:e22017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu S, Tian Z, Zhang L, Hou S, Hu S, Wu J,
Jing Y, Sun H, Yu F, Zhao L, et al: Combined cell surface carbonic
anhydrase 9 and CD147 antigens enable high-efficiency capture of
circulating tumor cells in clear cell renal cell carcinoma
patients. Oncotarget. 7:59877–59891. 2016.PubMed/NCBI
|
|
5
|
Xu G, Lu X, Huang T and Fan J: ARHGAP24
inhibits cell cycle progression, induces apoptosis and suppresses
invasion in renal cell carcinoma. Oncotarget. 7:51829–51839.
2016.PubMed/NCBI
|
|
6
|
El-Mokadem I, Kidd T, Pratt N, Fleming S
and Nabi G: Tumour suppressor gene (CDKNA2) status on chromosome 9p
in resected renal tissue improves prognosis of localised kidney
cancer. Oncotarget. 7:73045–73054. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang H, Chen Y, Liu X, Wang S, Lv Y, Wu D,
Wang Q, Luo M and Deng H: Downregulation of HSP60 disrupts
mitochondrial proteostasis to promote tumorigenesis and progression
in clear cell renal cell carcinoma. Oncotarget. 7:38822–38834.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kuang XL, Zhao XM, Xu HF, Shi YY, Deng JB
and Sun GT: Spatio-temporal expression of a novel neuron-derived
neurotrophic factor (NDNF) in mouse brains during development. BMC
Neurosci. 11:1372010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohashi K, Enomoto T, Joki Y, Shibata R,
Ogura Y, Kataoka Y, Shimizu Y, Kambara T, Uemura Y, Yuasa D, et al:
Neuron-derived neurotrophic factor functions as a novel modulator
that enhances endothelial cell function and revascularization
processes. J Biol Chem. 289:14132–14144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Joki Y, Ohashi K, Yuasa D, Shibata R,
Kataoka Y, Kambara T, Uemura Y, Matsuo K, Hayakawa S, Hiramatsu-Ito
M, et al: Neuron-derived neurotrophic factor ameliorates adverse
cardiac remodeling after experimental myocardial infarction. Circ
Heart Fail. 8:342–351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20–Nov;2018.(Epub
ahead of print).
|
|
12
|
Xie J, Zhu C, Wu J, Li C, Luo L, Xia L, Li
X, Gui Y, Cai Z and Li Z: Down-regulation of C12orf59 is associated
with a poor prognosis and VHL mutations in renal cell carcinoma.
Oncotarget. 7:6824–6834. 2016.PubMed/NCBI
|
|
13
|
Luo L, Wu J, Xie J, Xia L, Qian X, Cai Z
and Li Z: Downregulated ECRG4 is associated with poor prognosis in
renal cell cancer and is regulated by promoter DNA methylation.
Tumour Biol. 37:1121–1129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gumz ML, Zou H, Kreinest PA, Childs AC,
Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, et
al: Secreted frizzled-related protein 1 loss contributes to tumor
phenotype of clear cell renal cell carcinoma. Clin Cancer Res.
13:4740–4749. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lenburg ME, Liou LS, Gerry NP, Frampton
GM, Cohen HT and Christman MF: Previously unidentified changes in
renal cell carcinoma gene expression identified by parametric
analysis of microarray data. BMC Cancer. 3:312003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yusenko MV, Kuiper RP, Boethe T, Ljungberg
B, van Kessel AG and Kovacs G: High-resolution DNA copy number and
gene expression analyses distinguish chromophobe renal cell
carcinomas and renal oncocytomas. BMC Cancer. 9:1522009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou L, Chen J, Li Z, Li X, Hu X, Huang Y,
Zhao X, Liang C, Wang Y, Sun L, et al: Integrated profiling of
microRNAs and mRNAs: microRNAs located on Xq27.3 associate with
clear cell renal cell carcinoma. PLoS One. 5:e152242010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pickard A and McCance DJ: IGF-binding
protein 2-oncogene or tumor suppressor? Front Endocrinol
(Lausanne). 6(25)2015.PubMed/NCBI
|
|
21
|
Echizen K, Nakada M, Hayashi T, Sabit H,
Furuta T, Nakai M, Koyama-Nasu R, Nishimura Y, Taniue K, Morishita
Y, et al: PCDH10 is required for the tumorigenicity of glioblastoma
cells. Biochem Biophys Res Commun. 444:13–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Chim JC, Yang M, Ye J, Wong BC and
Qiao L: Role of PCDH10 and its hypermethylation in human gastric
cancer. Biochim Biophys Acta. 1823:298–305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Musgrove EA, Caldon CE, Barraclough J,
Stone A and Sutherland RL: Cyclin D as a therapeutic target in
cancer. Nat Rev Cancer. 11:558–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galichon P, Finianos S and Hertig A:
EMT-MET in renal disease: Should we curb our enthusiasm? Cancer
Lett. 341:24–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Piva F, Giulietti M, Santoni M, Occhipinti
G, Scarpelli M, Lopez-Beltran A, Cheng L, Principato G and
Montironi R: Epithelial to mesenchymal transition in renal cell
carcinoma: Implications for cancer therapy. Mol Diagn Ther.
20:111–117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han WQ, Zhu Q, Hu J, Li PL, Zhang F and Li
N: Hypoxia-inducible factor prolyl-hydroxylase-2 mediates
transforming growth factor beta 1-induced epithelial-mesenchymal
transition in renal tubular cells. Biochim Biophys Acta.
1833:1454–1462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McGuire JK, Li Q and Parks WC: Matrilysin
(matrix metalloproteinase-7) mediates E-cadherin ectodomain
shedding in injured lung epithelium. Am J Pathol. 162:1831–1843.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tan RJ, Zhou D, Zhou L and Liu Y:
Wnt/β-catenin signaling and kidney fibrosis. Kidney Int Suppl
(2011). 4:84–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
